HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Recurrent peptic ulcer after gastric surgery].

Abstract
Recurrent peptic ulcer after gastric surgery differs from duodenal ulcer in that they usually occur with low acid output, which is sufficient to cause ulceration in predisposed stomach or anastomosis. The proton pump inhibitor (PPI), significantly more potent and long-acting than H2-blocker, is expected to be more effective for postoperative recurrent ulcers. We evaluated the efficacy of omeprazole (OPZ) on recurrent ulcers in 12 patients following either gastrectomy or vagotomy. The healing rate after 4 week treatment with OPZ was 58% and increased to 100% after 8 week. Evaluation of quick symptom relief also supported the efficacy of OPZ treatment. These findings showed that OPZ treatment resulted in a more rapid healing of recurrent ulcers compared with H2-blocker. It remains to be clarified whether quit of treatment with PPI would induce high ulcer relapse rates, and whether maintenance therapy with PPI would be the only alternative therapy for surgical intervention.
AuthorsM Sugiyama, H Katamura
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 50 Issue 1 Pg. 144-53 (Jan 1992) ISSN: 0047-1852 [Print] Japan
PMID1311781 (Publication Type: Journal Article)
Chemical References
  • Gastrins
  • Adenosine Triphosphatases
  • H(+)-K(+)-Exchanging ATPase
  • Omeprazole
Topics
  • Adenosine Triphosphatases (antagonists & inhibitors)
  • Adult
  • Aged
  • Female
  • Gastrectomy
  • Gastric Acid (metabolism)
  • Gastrins (blood)
  • H(+)-K(+)-Exchanging ATPase
  • Humans
  • Male
  • Middle Aged
  • Omeprazole (therapeutic use)
  • Peptic Ulcer (drug therapy, physiopathology, surgery)
  • Postoperative Complications (drug therapy, physiopathology)
  • Recurrence
  • Vagotomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: